Does DIATRIZOATE MEGLUMINE Cause Off label use? 38 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 38 reports of Off label use have been filed in association with DIATRIZOATE MEGLUMINE (Cystografin). This represents 66.7% of all adverse event reports for DIATRIZOATE MEGLUMINE.
38
Reports of Off label use with DIATRIZOATE MEGLUMINE
66.7%
of all DIATRIZOATE MEGLUMINE reports
37
Deaths
37
Hospitalizations
How Dangerous Is Off label use From DIATRIZOATE MEGLUMINE?
Of the 38 reports, 37 (97.4%) resulted in death, 37 (97.4%) required hospitalization, and 37 (97.4%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DIATRIZOATE MEGLUMINE. However, 38 reports have been filed with the FAERS database.
What Other Side Effects Does DIATRIZOATE MEGLUMINE Cause?
Drug ineffective (38)
Rheumatoid arthritis (38)
Systemic lupus erythematosus (38)
Type 2 diabetes mellitus (38)
Drug hypersensitivity (37)
Pemphigus (37)
Pericarditis (37)
Psoriatic arthropathy (37)
Treatment failure (37)
Injection site reaction (36)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)